Earnings History Data for Enzo Biochem, Inc. (ENZ) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Enzo Biochem, Inc.

Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company's research is the development of products based on two technology platforms -- genetic modulation and immune modulation.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-12-2022	AH	4:30 PM ET (Dec 12)	ENZ	Enzo Biochem, Inc.	91.59	-0.18	0.00	-0.04	Enzo Biochem Non-GAAP EPS of -$0.18, revenue of $18.28M [12/12/2022 5:34 PM]	1.39	-0.47 (-25.14%)	1.80	-0.05 (-2.70%)	1.38 - 3.68	336,337	50,000	4,212
Enzo Biochem Non-GAAP EPS of -$0.18, revenue of $18.28M [12/12/2022 5:34 PM] Enzo Biochem Reports First Quarter Fiscal Year 2023 Financial Results and Provides Business Update [Dec-12-22 05:29PM]
14-10-2022	PM	7:00 AM ET (Oct 14)	ENZ	Enzo Biochem, Inc.	102.31	-0.17	0.00	0.07	Enzo Biochem Non-GAAP EPS of -$0.17, revenue of $20.28M [10/14/2022 7:36 AM]	2.08	-0.06 (-2.80%)	0.0	0.0 (0.00%)	1.98 - 3.95	44,554	30,000	0
Enzo Biochem Non-GAAP EPS of -$0.17, revenue of $20.28M [10/14/2022 7:36 AM] Enzo Biochem Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update [Oct-14-22 07:30AM]
09-06-2022	AH	4:05 PM ET (Jun 9)	ENZ	Enzo Biochem, Inc.	118.85	-0.09	0.00	0.04	Enzo Biochem GAAP EPS of -$0.10, revenue of $26.2M [6/9/2022 4:34 PM]	2.40	0.16 (6.93%)	0.0	0.0 (0.00%)	2.17 - 4.15	108,127	60,000	0
Enzo Biochem GAAP EPS of -$0.10, revenue of $26.2M [6/9/2022 4:34 PM] Enzo Biochem Reports Third Quarter Fiscal 2022 Results and Provides Leadership and Corporate Updates Including Engagement of Jefferies as Financial Advisor [Jun-09-22 04:30PM]
14-03-2022	AH	4:05 PM ET (Mar 14)	ENZ	Enzo Biochem, Inc.	154.62	0.03	0.00	0.09	Enzo Biochem Non-GAAP EPS of $0.03, revenue of $34.05M [3/14/2022 4:12 PM]	3.05	0.04 (1.33%)	3.01	0.0 (0.00%)	2.75 - 4.85	61,460	70,000	133
Enzo Biochem Non-GAAP EPS of $0.03, revenue of $34.05M [3/14/2022 4:12 PM] Enzo Biochem Reports Second Quarter Fiscal 2022 Result and Provides Leadership and Corporate Updates [Mar-14-22 04:10PM]
15-12-2021	AH	4:05 PM ET (Dec 15)	ENZ	Enzo Biochem, Inc.	171.59	-0.04	0.00	0.01	Enzo Biochem reports Q1 results [12/15/2021 4:09 PM]	3.23	-0.25 (-7.18%)	3.55	0.07 (2.01%)	2.22 - 4.85	271,679	130,000	508
Enzo Biochem reports Q1 results [12/15/2021 4:09 PM] Enzo Biochem Reports First Quarter 2022 Financial Results and Provides Business Update [Dec-15-21 04:05PM]
12-10-2021	PM	7:30 AM ET (Oct 12)	ENZ	Enzo Biochem, Inc.	188.07	0.07	0.00	-0.07	Enzo Biochem reports Q4 results [10/12/2021 7:29 AM]	3.80	-0.29 (-7.09%)	4.00	-0.09 (-2.20%)	1.80 - 4.85	380,191	280,000	100,778
Enzo Biochem reports Q4 results [10/12/2021 7:29 AM] Enzo Biochem shares fall after operational development update, Q4 results [10/12/2021 10:27 AM] Enzo Biochem Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update [Oct-12-21 07:00AM]
09-06-2021	AH	4:05 PM ET (Jun 9)	ENZ	Enzo Biochem, Inc.	148.06	0.04	0.00	-0.17	Enzo Biochem reports FQ3 results [6/9/2021 4:13 PM]	3.40	0.20 (6.25%)	3.36	0.16 (5.00%)	1.80 - 4.85	1,431,683	430,000	177,987
Enzo Biochem reports FQ3 results [6/9/2021 4:13 PM] Enzo Biochem rises as profitability continues after near twofold rise in revenue [6/10/2021 8:16 AM] Enzo Biochem Reports Third Quarter Fiscal 2021 Results [Jun-09-21 04:05PM]
15-03-2021	AH	4:05 PM ET (Mar 15)	ENZ	Enzo Biochem, Inc.	140.33	0.09	0.00	-0.12	Enzo Biochem reports FQ2 results [3/15/2021 4:10 PM]	4.02	1.06 (35.81%)	3.91	0.95 (32.09%)	1.56 - 4.85	46,804,361	981,109	2,103,303
Enzo Biochem reports FQ2 results [3/15/2021 4:10 PM] Enzo Biochem CEO to step down [3/15/2021 4:30 PM] Enzo Biochem moves commended by top investor [3/16/2021 4:05 PM] Gene editing will boost intelligence within a few decades [Mar-12-21 08:00AM] Enzo Biochem, Inc. to Host Earnings Call [Mar-15-21 02:30PM] Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company Provides Leadership and Corporate Updates [Mar-15-21 04:05PM] The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study [Mar-16-21 08:17AM] Enzo Biochem Blasts Higher as Revenue Jumps 62% [Mar-16-21 09:59AM]
09-12-2020	AH	4:05 PM ET (Dec 9)	ENZ	Enzo Biochem, Inc.	118.52	0.01	0.00	-0.16	Enzo Biochem reports Q1 results [12/9/2020 4:05 PM]	2.50	0.01 (0.40%)	2.54	0.05 (2.01%)	1.56 - 4.85	645,919	374,239	14,391
Enzo Biochem reports Q1 results [12/9/2020 4:05 PM] Shareholders at Embattled Enzo Biochem Want Answers [Dec-09-20 03:45PM] Enzo Biochem, Inc. to Host Earnings Call [Dec-09-20 02:30PM]
13-10-2020	AH	4:05 PM ET (Oct 13)	ENZ	Enzo Biochem, Inc.	110.63	-0.07	0.00	-0.11	Enzo Biochem reports FQ4 results [10/13/2020 4:04 PM]	2.16	-0.45 (-17.24%)	2.25	-0.36 (-13.79%)	1.56 - 4.85	1,166,612	253,159	65,286